EP0964699A4 - NUCLEIC ACID AND AMINO ACID SEQUENCES OF HELIOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF - Google Patents

NUCLEIC ACID AND AMINO ACID SEQUENCES OF HELIOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF

Info

Publication number
EP0964699A4
EP0964699A4 EP97954525A EP97954525A EP0964699A4 EP 0964699 A4 EP0964699 A4 EP 0964699A4 EP 97954525 A EP97954525 A EP 97954525A EP 97954525 A EP97954525 A EP 97954525A EP 0964699 A4 EP0964699 A4 EP 0964699A4
Authority
EP
European Patent Office
Prior art keywords
helicobacter pylori
vaccine compositions
amino acid
nucleic acid
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97954525A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0964699A1 (en
Inventor
Douglas Smith
Richard A Alm
Peter C Doig
Zita Kabok
Lillian Marie Castriotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of EP0964699A1 publication Critical patent/EP0964699A1/en
Publication of EP0964699A4 publication Critical patent/EP0964699A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP97954525A 1996-12-05 1997-12-05 NUCLEIC ACID AND AMINO ACID SEQUENCES OF HELIOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF Withdrawn EP0964699A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US75962596A 1996-12-05 1996-12-05
US759625 1996-12-05
US82374597A 1997-03-25 1997-03-25
US823745 1997-03-25
US89192897A 1997-07-14 1997-07-14
US891928 1997-07-14
PCT/US1997/022104 WO1998024475A1 (en) 1996-12-05 1997-12-05 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (2)

Publication Number Publication Date
EP0964699A1 EP0964699A1 (en) 1999-12-22
EP0964699A4 true EP0964699A4 (en) 2005-04-06

Family

ID=27419527

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97954525A Withdrawn EP0964699A4 (en) 1996-12-05 1997-12-05 NUCLEIC ACID AND AMINO ACID SEQUENCES OF HELIOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF

Country Status (18)

Country Link
EP (1) EP0964699A4 (xx)
JP (1) JP2001510992A (xx)
KR (1) KR20000069297A (xx)
CN (1) CN1246799A (xx)
AR (1) AR010337A1 (xx)
AU (1) AU739641B2 (xx)
BR (1) BR9714133A (xx)
CA (1) CA2273199A1 (xx)
EE (1) EE9900226A (xx)
ID (1) ID21946A (xx)
IL (1) IL129746A0 (xx)
IS (1) IS5047A (xx)
NO (1) NO992158L (xx)
NZ (1) NZ335633A (xx)
PL (1) PL333943A1 (xx)
SK (1) SK57999A3 (xx)
TR (1) TR199901262T2 (xx)
WO (1) WO1998024475A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6188599A (en) * 1998-10-26 2000-05-15 Novozymes A/S Constructing and screening a dna library of interest in filamentous fungal cells
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
AU2000277557A1 (en) * 2000-10-06 2002-04-22 Smith Kline Beecham Corporation Methods of agonizing and antagonizing fabk
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
CN102176907A (zh) * 2008-10-08 2011-09-07 免疫解决方案有限公司 用于产生粘膜免疫的口服疫苗
JP6959937B2 (ja) * 2015-12-14 2021-11-05 テクニシェ ユニバーシタット ミュンヘン ヘリコバクターピロリワクチン
CN110343697B (zh) * 2019-08-05 2024-07-12 南京昊斯亭网络科技有限公司 一种植物病害菌总dna提取方法
CN113435168B (zh) * 2021-06-10 2024-03-22 上海美吉生物医药科技有限公司 胶图自动编辑方法、系统、终端及介质
CN114057854B (zh) * 2021-09-30 2022-07-15 河北医科大学第四医院 一种幽门螺杆菌cd4+t细胞耐受多肽融合抗原及其应用
CN116162140A (zh) * 2022-07-19 2023-05-26 四川大学华西医院 一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016714A1 (en) * 1993-01-19 1994-08-04 Medicarb Ab The use of a composition for the treatment of infections caused by helicobacter pylori

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016714A1 (en) * 1993-01-19 1994-08-04 Medicarb Ab The use of a composition for the treatment of infections caused by helicobacter pylori

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 25 August 1997 (1997-08-25), TOMB, J.-F. ET AL.: "Helicobacter pylori section 3 of 134 of the complete genome", Database accession no. AE000525 *
DATABASE UniProt 1 January 1998 (1998-01-01), TOMB, J.-F. ET AL.: "Outer membrane protein (Omp2)", Database accession no. O224870 *
JEAN-F. TOMB ET AL.: "The complete genome sequence of the gastric pathogen Helicobacter pylori", NATURE, vol. 389, 25 September 1997 (1997-09-25), pages 539 - 547, XP002062106 *
SCHMITT W ET AL: "GENETIC ANALYSIS OF THE HELICOBACTER PYLORI VACUOLATING CYTOTOXIN: STRUCTURAL SIMILARITIES WITH THE IGA PROTEASE TYPE OF EXPORTED PROTEIN", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 12, no. 2, 1 April 1994 (1994-04-01), pages 307 - 319, XP000605827, ISSN: 0950-382X *
See also references of WO9824475A1 *

Also Published As

Publication number Publication date
TR199901262T2 (xx) 1999-08-23
AR010337A1 (es) 2000-06-07
AU5895498A (en) 1998-06-29
CN1246799A (zh) 2000-03-08
SK57999A3 (en) 2000-05-16
EE9900226A (et) 1999-12-15
KR20000069297A (ko) 2000-11-25
PL333943A1 (en) 2000-01-31
AU739641B2 (en) 2001-10-18
NO992158L (no) 1999-07-05
BR9714133A (pt) 2000-02-29
CA2273199A1 (en) 1998-06-11
EP0964699A1 (en) 1999-12-22
WO1998024475A1 (en) 1998-06-11
IL129746A0 (en) 2000-02-29
IS5047A (is) 1999-05-10
NZ335633A (en) 2000-10-27
ID21946A (id) 1999-08-12
JP2001510992A (ja) 2001-08-07
NO992158D0 (no) 1999-05-04

Similar Documents

Publication Publication Date Title
SK165197A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
HUP0100267A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL122340A0 (en) Helicobacter pylori antigens and vaccine compositions
IL129397A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL129746A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL130608A0 (en) Novel nucleic and amino acid sequence
AU1698699A (en) (helicobacter pylori) vaccine formulations
EP1235841A4 (en) TRIGGERING MAGE2 / 3 CELLULAR IMMUNE RESPONSES USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
AU1055497A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
ZA979672B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof
HUP9903843A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP0000521A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
ZA9710934B (en) Compositions and methods for administering pneumococal dna
ZA9710971B (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof.
ZA972715B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof.
HUP9900766A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
ZA964869B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
EP1071325A4 (en) COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
GB9413073D0 (en) Helicobacter pylori vaccines/therapeutic compositions
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции
AU7537598A (en) Dna based anti-(helicobacter) vaccine composition
GB9610192D0 (en) DNA vaccine formulations
IL129027A0 (en) Novel nucleic acid and amino acid sequence

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990705

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT PAYMENT 19990705;LV PAYMENT 19990705;MK PAYMENT 19990705;RO PAYMENT 19990705;SI PAYMENT 19990705

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ASTRAZENECA AB

RTI1 Title (correction)

Free format text: NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/68 B

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 39/106 B

Ipc: 7C 07K 19/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 14/205 B

Ipc: 7C 12N 15/31 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050218

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050513

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1024176

Country of ref document: HK